Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pet Medication market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pet Medication market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pet Medication market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pet Medication products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pet Medication products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pet Medication market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pet Medication development has been the leading industry trend of Pet Medication market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pet Medication Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Antibiotics, Antifungal, Flea Products, Other |
| By Application Outlook |
Cat, Dog, Horse, Fish, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Zoetis
- Merck
- Elanco
- Bayer
- Boehringer
- Novartis
- Virbac
- Ceva
- Vetoquinol
- Nexvet
- Aratana Therapeutics
- Kindred Biosciences
- Ambrx
- Entest Biomedical
- Taconic Biosciences
Pet Medication Market, By Type
- Antibiotics
- Antifungal
- Flea Products
- Other
Pet Medication Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Pet Medication Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pet Medication Market Size Growth Rate by Product
1.4.2 Antibiotics
1.4.3 Antifungal
1.4.4 Flea Products
1.5 Market by End User
1.5.1 Global Pet Medication Market Size Growth Rate by End User
1.5.2 Cat
1.5.3 Dog
1.5.4 Horse
1.5.5 Fish
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pet Medication Market Size
2.1.1 Global Pet Medication Revenue 2017-2027
2.1.2 Global Pet Medication Sales 2017-2027
2.2 Pet Medication Growth Rate by Regions
2.2.1 Global Pet Medication Sales by Regions
2.2.2 Global Pet Medication Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pet Medication Sales by Manufacturers
3.1.1 Pet Medication Sales by Manufacturers
3.1.2 Pet Medication Sales Market Share by Manufacturers
3.1.3 Global Pet Medication Market Concentration Ratio (CR5 and HHI)
3.2 Pet Medication Revenue by Manufacturers
3.2.1 Pet Medication Revenue by Manufacturers (2017-2020)
3.2.2 Pet Medication Revenue Share by Manufacturers (2017-2020)
3.3 Pet Medication Price by Manufacturers
3.4 Pet Medication Manufacturing Base Distribution, Product Types
3.4.1 Pet Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Medication Product Type
3.4.3 Date of International Manufacturers Enter into Pet Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pet Medication Sales by Product
4.2 Global Pet Medication Revenue by Product
4.3 Pet Medication Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pet Medication Breakdown Data by End User
6 North America
6.1 North America Pet Medication by Countries
6.1.1 North America Pet Medication Sales by Countries
6.1.2 North America Pet Medication Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pet Medication by Product
6.3 North America Pet Medication by End User
7 Europe
7.1 Europe Pet Medication by Countries
7.1.1 Europe Pet Medication Sales by Countries
7.1.2 Europe Pet Medication Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Medication by Product
7.3 Europe Pet Medication by End User
8 Asia Pacific
8.1 Asia Pacific Pet Medication by Countries
8.1.1 Asia Pacific Pet Medication Sales by Countries
8.1.2 Asia Pacific Pet Medication Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pet Medication by Product
8.3 Asia Pacific Pet Medication by End User
9 Central & South America
9.1 Central & South America Pet Medication by Countries
9.1.1 Central & South America Pet Medication Sales by Countries
9.1.2 Central & South America Pet Medication Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pet Medication by Product
9.3 Central & South America Pet Medication by End User
10 Middle East and Africa
10.1 Middle East and Africa Pet Medication by Countries
10.1.1 Middle East and Africa Pet Medication Sales by Countries
10.1.2 Middle East and Africa Pet Medication Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pet Medication by Product
10.3 Middle East and Africa Pet Medication by End User
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Company Business Overview
11.1.3 Zoetis Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Zoetis Pet Medication Products Offered
11.1.5 Zoetis Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Merck Pet Medication Products Offered
11.2.5 Merck Recent Development
11.3 Elanco
11.3.1 Elanco Company Details
11.3.2 Company Business Overview
11.3.3 Elanco Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Elanco Pet Medication Products Offered
11.3.5 Elanco Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Business Overview
11.4.3 Bayer Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Bayer Pet Medication Products Offered
11.4.5 Bayer Recent Development
11.5 Boehringer
11.5.1 Boehringer Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Boehringer Pet Medication Products Offered
11.5.5 Boehringer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Novartis Pet Medication Products Offered
11.6.5 Novartis Recent Development
11.7 Virbac
11.7.1 Virbac Company Details
11.7.2 Company Business Overview
11.7.3 Virbac Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Virbac Pet Medication Products Offered
11.7.5 Virbac Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Company Business Overview
11.8.3 Ceva Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Ceva Pet Medication Products Offered
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Company Business Overview
11.9.3 Vetoquinol Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Vetoquinol Pet Medication Products Offered
11.9.5 Vetoquinol Recent Development
11.10 Nexvet
11.10.1 Nexvet Company Details
11.10.2 Company Business Overview
11.10.3 Nexvet Pet Medication Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Nexvet Pet Medication Products Offered
11.10.5 Nexvet Recent Development
11.11 Aratana Therapeutics
11.12 Kindred Biosciences
11.13 Ambrx
11.14 Entest Biomedical
11.15 Taconic Biosciences
12 Future Forecast
12.1 Pet Medication Market Forecast by Regions
12.1.1 Global Pet Medication Sales Forecast by Regions 2021-2027
12.1.2 Global Pet Medication Revenue Forecast by Regions 2021-2027
12.2 Pet Medication Market Forecast by Product
12.2.1 Global Pet Medication Sales Forecast by Product 2021-2027
12.2.2 Global Pet Medication Revenue Forecast by Product 2021-2027
12.3 Pet Medication Market Forecast by End User
12.4 North America Pet Medication Forecast
12.5 Europe Pet Medication Forecast
12.6 Asia Pacific Pet Medication Forecast
12.7 Central & South America Pet Medication Forecast
12.8 Middle East and Africa Pet Medication Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
